denkapparat Operations GmbH purchased a new stake in DaVita Inc. (NYSE:DVA – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 1,758 shares of the company’s stock, valued at approximately $263,000.
Several other institutional investors have also added to or reduced their stakes in DVA. New Age Alpha Advisors LLC acquired a new stake in shares of DaVita in the 4th quarter valued at about $1,782,000. Norges Bank purchased a new stake in DaVita in the 4th quarter valued at $7,297,000. Caisse Des Depots ET Consignations bought a new position in shares of DaVita during the fourth quarter valued at about $1,682,000. UniSuper Management Pty Ltd boosted its stake in shares of DaVita by 21.8% in the 4th quarter. UniSuper Management Pty Ltd now owns 11,506 shares of the company’s stock worth $1,721,000 after buying an additional 2,063 shares during the last quarter. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new position in DaVita in the fourth quarter worth $449,000. 90.12% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of analysts have issued reports on DVA shares. StockNews.com downgraded DaVita from a “buy” rating to a “hold” rating in a research report on Friday, March 21st. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Barclays boosted their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. According to MarketBeat, DaVita currently has a consensus rating of “Hold” and a consensus target price of $166.33.
DaVita Trading Down 1.5 %
Shares of DVA stock opened at $150.29 on Friday. The business has a 50-day moving average price of $157.39 and a two-hundred day moving average price of $157.50. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The firm has a market cap of $12.02 billion, a P/E ratio of 13.99, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.
DaVita (NYSE:DVA – Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities analysts anticipate that DaVita Inc. will post 10.76 EPS for the current fiscal year.
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Articles
- Five stocks we like better than DaVita
- When to Sell a Stock for Profit or Loss
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What Are Dividend Challengers?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Breakout Stocks: What They Are and How to Identify Them
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.